Cohort Study of Chronic Liver Disease Complicated by Sepsis
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Study ID
- NCT07465003
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cirrhosis
- Sepsis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study
Key Dates
- First listed
- Mar 11, 2026
- Start date
- Feb 25, 2026
- Status verified
- Sep 2025
- Primary completion
- Feb 25, 2027
- Completion
- Jun 1, 2028
Study Design
- Enrollment
- 1,600 participants (estimated)
Primary Outcome Measure
28-day all-cause mortality in cirrhosis with sepsis [ Time Frame: Baseline and 28 days. ]
Central Contacts
- Li ShiYing Deputy Chief Physician of the Department of Infectious Disease, Ph.D0086+18623322462
Related Studies
- Alveolar Dead Space as Predictor of Organ Failure in Severe SepsisNot Yet Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?Recruiting · Michigan State University · Lansing, Michigan
- Biomarkers in InfectionRecruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts
- Blood Collection Biorepository for Liver Disease ResearchRecruiting · State University of New York at Buffalo · Buffalo, New York